161 related articles for article (PubMed ID: 25092054)
1. GMP-grade human fetal liver-derived mesenchymal stem cells for clinical transplantation.
Larijani B; Aghayan HR; Goodarzi P; Arjmand B
Methods Mol Biol; 2015; 1283():123-36. PubMed ID: 25092054
[TBL] [Abstract][Full Text] [Related]
2. GMP-compliant human adipose tissue-derived mesenchymal stem cells for cellular therapy.
Aghayan HR; Goodarzi P; Arjmand B
Methods Mol Biol; 2015; 1283():93-107. PubMed ID: 25138723
[TBL] [Abstract][Full Text] [Related]
3. Production of good manufacturing practice-grade human umbilical cord blood-derived mesenchymal stem cells for therapeutic use.
Van Pham P; Phan NK
Methods Mol Biol; 2015; 1283():73-85. PubMed ID: 25239529
[TBL] [Abstract][Full Text] [Related]
4. Isolation and Manufacture of Clinical-Grade Bone Marrow-Derived Human Mesenchymal Stromal Cells.
Miller RP; Hanley PJ
Methods Mol Biol; 2016; 1416():301-12. PubMed ID: 27236680
[TBL] [Abstract][Full Text] [Related]
5. cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells.
Veronesi E; Burns JS; Murgia A; Candini O; Rasini V; Mastrolia I; Catani F; Paolucci P; Dominici M
Methods Mol Biol; 2015; 1283():109-22. PubMed ID: 25108453
[TBL] [Abstract][Full Text] [Related]
6. Clinical grade production of mesenchymal stem cells.
Sensebé L
Biomed Mater Eng; 2008; 18(1 Suppl):S3-10. PubMed ID: 18334718
[TBL] [Abstract][Full Text] [Related]
7. Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank.
Chatzistamatiou TK; Papassavas AC; Michalopoulos E; Gamaloutsos C; Mallis P; Gontika I; Panagouli E; Koussoulakos SL; Stavropoulos-Giokas C
Transfusion; 2014 Dec; 54(12):3108-20. PubMed ID: 24894363
[TBL] [Abstract][Full Text] [Related]
8. Standard operating procedure for the good manufacturing practice-compliant production of human bone marrow mesenchymal stem cells.
Roseti L; Serra M; Bassi A
Methods Mol Biol; 2015; 1283():171-86. PubMed ID: 25092055
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application.
Torre ML; Lucarelli E; Guidi S; Ferrari M; Alessandri G; De Girolamo L; Pessina A; Ferrero I;
Stem Cells Dev; 2015 Mar; 24(6):677-85. PubMed ID: 25517941
[TBL] [Abstract][Full Text] [Related]
10. GMP-Compliant Production of Human Placenta-Derived Mesenchymal Stem Cells.
Aghayan HR; Payab M; Mohamadi-Jahani F; Aghayan SS; Larijani B; Arjmand B
Methods Mol Biol; 2021; 2286():213-225. PubMed ID: 32504292
[TBL] [Abstract][Full Text] [Related]
11. Clinical grade expansion of MSCs.
Capelli C; Pedrini O; Valgardsdottir R; Da Roit F; Golay J; Introna M
Immunol Lett; 2015 Dec; 168(2):222-7. PubMed ID: 26092523
[TBL] [Abstract][Full Text] [Related]
12. Using the quantum cell expansion system for the automated expansion of clinical-grade bone marrow-derived human mesenchymal stromal cells.
Martin-Manso G; Hanley PJ
Methods Mol Biol; 2015; 1283():53-63. PubMed ID: 25523809
[TBL] [Abstract][Full Text] [Related]
13. Generation of mesenchymal stem cells as a medicinal product in organ transplantation.
Verbeek R
Curr Opin Organ Transplant; 2013 Feb; 18(1):65-70. PubMed ID: 23222173
[TBL] [Abstract][Full Text] [Related]
14. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
[TBL] [Abstract][Full Text] [Related]
15. Support of hepatic regeneration by trophic factors from liver-derived mesenchymal stromal/stem cells.
Fouraschen SM; Hall SR; de Jonge J; van der Laan LJ
Methods Mol Biol; 2014; 1213():89-104. PubMed ID: 25173377
[TBL] [Abstract][Full Text] [Related]
16. Quality control and monitoring for the isolation process of mesenchymal stem cells and their differentiation into osteoblasts.
Kawauchi S; Terasaki H; Katano M; Murase J; Masuda Y; Tamura T; Shimadzu M
Genet Test Mol Biomarkers; 2010 Apr; 14(2):269-82. PubMed ID: 20187761
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of the environmental bacterial and fungi contamination in a pharmaceutical unit of mesenchymal stem cell for clinical use.
Martín PG; González MB; Martínez AR; Lara VG; Naveros BC
Biologicals; 2012 Sep; 40(5):330-7. PubMed ID: 22795333
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic mesenchymal stromal cells: where we are headed.
Hanley PJ
Methods Mol Biol; 2015; 1283():1-11. PubMed ID: 25537839
[TBL] [Abstract][Full Text] [Related]
19. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
Wuchter P; Bieback K; Schrezenmeier H; Bornhäuser M; Müller LP; Bönig H; Wagner W; Meisel R; Pavel P; Tonn T; Lang P; Müller I; Renner M; Malcherek G; Saffrich R; Buss EC; Horn P; Rojewski M; Schmitt A; Ho AD; Sanzenbacher R; Schmitt M
Cytotherapy; 2015 Feb; 17(2):128-39. PubMed ID: 24856898
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the cGMP manufacturing of MSCs for multicenter academia trials.
McKenna D
Transfusion; 2016 Apr; 56(4):18S-9S. PubMed ID: 27079316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
